Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 12,018 |
|
|||||
| News | - | ||||||
| Day High | 0.74 | Low High |
|||||
| Day Low | 0.70 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alzamend Neuro Inc | ALZN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.022 | 3.14% | 0.722 | 13:57:18 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.74 | 0.70 | 0.74 | 0.70 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 69 | 12,018 | $ 0.7299348 | $ 8,772 | - | 0.6516 - 11.91 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:28:08 | 1 | $ 0.722 | USD |
Alzamend Neuro Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.13M | 7.12M | - | 0 | -14.88M | -2.09 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alzamend Neuro News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALZN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.714 | 0.74 | 0.6516 | 0.694911 | 28,177 | 0.008 | 1.12% |
| 1 Month | 0.99 | 0.99 | 0.6516 | 0.8149635 | 47,249 | -0.268 | -27.07% |
| 3 Months | 0.8815 | 1.29 | 0.6516 | 0.9977988 | 57,944 | -0.1595 | -18.09% |
| 6 Months | 2.931 | 3.00 | 0.6516 | 1.30 | 114,107 | -2.21 | -75.37% |
| 1 Year | 8.25 | 11.91 | 0.6516 | 4.19 | 149,432 | -7.53 | -91.25% |
| 3 Years | 435.00 | 503.25 | 0.6516 | 41.99 | 1,221,391 | -434.28 | -99.83% |
| 5 Years | 435.00 | 503.25 | 0.6516 | 41.99 | 1,221,391 | -434.28 | -99.83% |
Alzamend Neuro Description
| Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. |
